comunicacio

IDIBELL scientists identify the PI4KA gene as the cause of a new neurological disease

Neurometabolic diseases , Neuroscience Area, Neuroscience Program / By

The study has identified mutations of this gene in ten families and biochemical studies in the laboratory have confirmed that these variants are responsible for the symptoms. Possible treatments have already been tested through massive drug analyzes, which will then be tested in mini-brains generated from cells of the patients.

IDIBELL scientists identify the PI4KA gene as the cause of a new neurological disease Read More »

The Spanish State at the forefront of Europe in young waterpipe tobacco smokers

Cancer, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Tobacco control research  / By

A study in which IDIBELL and ICO professionals have participated confirms that 90% of electronic cigarette smokers also consume conventional cigarettes and warns that social networks are becoming a channel of promotion, covertly or indirectly, of tobacco products banned by the European Tobacco Products Directive (TPD).

The Spanish State at the forefront of Europe in young waterpipe tobacco smokers Read More »

New diagnostic biomarkers and new therapeutic targets for the minority disease Lymphangioleiomyomatosis

Breast cancer, Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell / By

A study by IDIBELL and the ICO, with the collaboration of the Spanish LAM Association, has detected that patients suffering from Lymphangioleiomyomatosis have elevated plasma levels of a histamine derivative, which could be used for the diagnosis of the disease.

New diagnostic biomarkers and new therapeutic targets for the minority disease Lymphangioleiomyomatosis Read More »

An international study with IDIBELL participation associates new genetic and immunological defects with severe COVID-19

Neurometabolic diseases , Neuroscience Area, Neuroscience Program / By

TLR7 gene is essential for shaping response mechanisms to the virus and having deficiencies can lead to severe cases of SARS-CoV-2 in young people. The presence of autoantibodies against type I interferons increases with age and it is confirmed that it would increase the severity of COVID-19 in people older than 70 years.

An international study with IDIBELL participation associates new genetic and immunological defects with severe COVID-19 Read More »

Dr. Sebastiano Biondo obtains the position of Professor of Surgery at the University of Barcelona

Digestive system, diagnostics, pharmacogenetics, care support and clinical prevention Program, Digestive tract pathology, Translational Medicine Area / By

Dr. Sebastiano Biondo, head of the Digestive Tube Pathology research group at IDIBELL and the Bellvitge University Hospital, has obtained the position of Professor of Surgery at the University of Barcelona in the competition held on July 20.

Dr. Sebastiano Biondo obtains the position of Professor of Surgery at the University of Barcelona Read More »

Pancreatic beta-cell boost in mice paves way for future diabetes treatments

Pancreas regeneration: pancreatic progenitors and their niche, Regenerative Medicine Area, Regenerative Medicine Program / By

A research team from IDIBELL, CRG and UB has uncovered the role of a gene that is critical to boosting the number of insulin-producing cells during the early development of the pancreas. The findings could bolster diabetes research efforts and eventually lead to new replacement therapies for the disease.

Pancreatic beta-cell boost in mice paves way for future diabetes treatments Read More »

Identified two new genes implicated in developmental brain diseases

Genes, Disease and Therapy Program, Physiology and pathology of the functional relationship between glia and neurons , Translational Medicine Area / By

Two studies with the participation of IDIBELL and the University of Barcelona have identified mutations in the CLCN3 gene, encoding a chloride transporter in endosomes, and the CHRM1 gene, corresponding to the M1 muscarinic neuronal receptor, as responsible for defects in brain development.

Identified two new genes implicated in developmental brain diseases Read More »

New advances in the characterization of the minority disease Limfangioleiomyomatosis

Breast cancer, Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell / By

A team from IDIBELL and the ICO, through gene and protein expression analysis of the disease, has determined the biological traits that would explain the high heterogeneity and molecular similarities with cancer.

New advances in the characterization of the minority disease Limfangioleiomyomatosis Read More »

Scroll to Top